Literature DB >> 8951536

The 1996 Lindberg Award. Calcium antagonists alter cell shape and induce procollagenase synthesis in keloid and normal human dermal fibroblasts.

H Doong1, S Dissanayake, T R Gowrishankar, M C LaBarbera, R C Lee.   

Abstract

Fibroblast cytomorphology is tightly coupled to phenotypic expression, particularly as it relates to extracellular matrix protein synthesis and degradation. We have observed that calcium antagonists, such as verapamil and trifluoperazine, depolymerize actin filaments and alter fibroblast cell shape from bipolar to spherical. Characteristically, the depolymerization of actin filaments, which mediates the cell shape change, turns on procollagenase gene expression in normal human skin fibroblasts. We have found the same effects of calcium antagonists on cell shape, cytoskeletal components, and induction of procollagenase in the keloid fibroblasts of three cell lines, CB792, CW792, and WT949. Rounded cells were seen in 74.8% of verapamil-treated and 86.7% of trifluoperazine-treated cells, whereas only 1.1% of the control cells were spherical. The percentage of cells that synthesized collagenase in the control, verapamil-treated, and trifluoperazine-treated groups was 3.8%, 42.8%, and 53.4%, respectively. Approximately 60% of rounded cells exhibited increased collagenase synthesis when the cells were treated with a calcium antagonist. These results indicate considerable heterogeneity in the phenotypic response to morphologic change. The amount of procollagenase synthesized in a cell was estimated by the fluorescence intensity of the fluorescein-labeled antibody. The normalized fluorescence intensity of procollagenase in the control cells was about 2 to 2.6 times that of background. In contrast, the normalized fluorescence intensity of procollagenase in the calcium antagonist-treated cells was about 2.4 to 12 times that of background. This high intensity level indicates an increase in procollagenase production in the calcium antagonist-treated cells. Calcium green dye used to study cytosolic calcium revealed that after cells were treated with verapamil, the cytosolic calcium ion concentration first increased and then decreased. The change of cytosolic calcium ion concentration may be related to the depolymerization of actin filaments and the alteration of cell shape.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8951536

Source DB:  PubMed          Journal:  J Burn Care Rehabil        ISSN: 0273-8481


  12 in total

Review 1.  Prevention and treatment of excessive dermal scarring.

Authors:  Ingrid E Roseborough; Mark A Grevious; Raphael C Lee
Journal:  J Natl Med Assoc       Date:  2004-01       Impact factor: 1.798

2.  Management of keloid and hypertrophic scars.

Authors:  A S Edriss; J Mesták
Journal:  Ann Burns Fire Disasters       Date:  2005-12-31

3.  [Hyperplastic scars and keloids. Part I: basics and prevention].

Authors:  A Baisch; F Riedel
Journal:  HNO       Date:  2006-11       Impact factor: 1.284

4.  Role of verapamil in preventing and treating hypertrophic scars and keloids.

Authors:  Ru Wang; Yu Mao; Zhenyu Zhang; Zhengyong Li; Junjie Chen; Ying Cen
Journal:  Int Wound J       Date:  2015-05-12       Impact factor: 3.315

5.  Effect of intralesional verapamil for treatment of Peyronie's disease: a randomized single-blind, placebo-controlled study.

Authors:  M Shirazi; A R Haghpanah; M Badiee; M A Afrasiabi; S Haghpanah
Journal:  Int Urol Nephrol       Date:  2009-02-06       Impact factor: 2.370

6.  Nitric Oxide Produced by the Antioxidant Activity of Verapamil Improves the Acute Wound Healing Process.

Authors:  Yu Na Han; Yoon Jae Lee; Ki Joo Kim; Su Jin Lee; Jang Youn Choi; Suk-Ho Moon; Jong Won Rhie
Journal:  Tissue Eng Regen Med       Date:  2021-01-29       Impact factor: 4.169

7.  Pharmacological therapy in patients diagnosed with Peyronie's disease.

Authors:  A A Halal; P Geavlete; E Ceban
Journal:  J Med Life       Date:  2012-06-18

8.  The Efficacy of Triamcinolone Acetonide in Keloid Treatment: A Systematic Review and Meta-analysis.

Authors:  Thian-Sze Wong; John Zeng-Hong Li; Siqi Chen; Jimmy Yu-Wai Chan; Wei Gao
Journal:  Front Med (Lausanne)       Date:  2016-12-27

9.  Verapamil inhibits scar formation after peripheral nerve repair in vivo.

Authors:  A-Chao Han; Jing-Xiu Deng; Qi-Shun Huang; Huai-Yuan Zheng; Pan Zhou; Zhi-Wei Liu; Zhen-Bing Chen
Journal:  Neural Regen Res       Date:  2016-03       Impact factor: 5.135

Review 10.  Triamcinolone acetonide intralesional injection for the treatment of keloid scars: patient selection and perspectives.

Authors:  Marco Morelli Coppola; Rosa Salzillo; Francesco Segreto; Paolo Persichetti
Journal:  Clin Cosmet Investig Dermatol       Date:  2018-07-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.